Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis

Wenbo Zhang, Jean Marc Navenot, Nicole M. Frilot, Nobutaka Fujii, Stephen C. Peiper

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

CXCR4, the primary receptor for CXCL12, plays a critical role in the development of hematopoietic, vascular, central nervous, and immune systems by mediating directional migration of precursor cells. This mechanism promotes homing of tumor cells to metastatic sites that secrete CXCL12, and CXCR4 expression is a negative prognostic factor in acute myelogenous leukemia (AML). To elucidate mechanisms that regulate CXCR4 signaling, we used a proteomic approach to identify proteins physically associated with CXCR4. Analysis of CXCR4 immune complexes identified nucleophosmin (NPM), which was confirmed by reciprocal coimmunoprecipitation for NPM. Constitutively active CXCR4 variants bound higher levels of NPM than the wild-type receptor, which was reversed by T140, an inverse agonist. NPM binding to CXCR4 localized interactions to the C terminus and cytoplasmic loop (CL)-3, but not CL-1 or CL-2. Alanine scanning mutagenesis demonstrated that positively charged amino acids in CL-3 were critical for NPM binding. Recombinant NPM decreased GTP binding in membrane fractions after activation of CXCR4 by CXCL12. Suppression of NPM expression enhanced chemotactic responses to CXCL12, and, conversely, overexpression of a cytosolic NPM mutant reduced chemotaxis induced by CXCL12. This study provides evidence for a novel role for NPM as a negative regulator of CXCR4 signaling induced by CXCL12 that may be relevant to the biology of AML.

Original languageEnglish (US)
Pages (from-to)1310-1321
Number of pages12
JournalMolecular Pharmacology
Volume72
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Chemotaxis
GTP-Binding Proteins
Acute Myeloid Leukemia
CXCR4 Receptors
nucleophosmin
Guanosine Triphosphate
Antigen-Antibody Complex
Mutagenesis
Alanine
Proteomics
Cell Movement
Blood Vessels
Immune System
Central Nervous System
Amino Acids
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis. / Zhang, Wenbo; Navenot, Jean Marc; Frilot, Nicole M.; Fujii, Nobutaka; Peiper, Stephen C.

In: Molecular Pharmacology, Vol. 72, No. 5, 11.2007, p. 1310-1321.

Research output: Contribution to journalArticle

Zhang, Wenbo ; Navenot, Jean Marc ; Frilot, Nicole M. ; Fujii, Nobutaka ; Peiper, Stephen C. / Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis. In: Molecular Pharmacology. 2007 ; Vol. 72, No. 5. pp. 1310-1321.
@article{2655164b7955410cbc365a5d8ea3bed8,
title = "Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis",
abstract = "CXCR4, the primary receptor for CXCL12, plays a critical role in the development of hematopoietic, vascular, central nervous, and immune systems by mediating directional migration of precursor cells. This mechanism promotes homing of tumor cells to metastatic sites that secrete CXCL12, and CXCR4 expression is a negative prognostic factor in acute myelogenous leukemia (AML). To elucidate mechanisms that regulate CXCR4 signaling, we used a proteomic approach to identify proteins physically associated with CXCR4. Analysis of CXCR4 immune complexes identified nucleophosmin (NPM), which was confirmed by reciprocal coimmunoprecipitation for NPM. Constitutively active CXCR4 variants bound higher levels of NPM than the wild-type receptor, which was reversed by T140, an inverse agonist. NPM binding to CXCR4 localized interactions to the C terminus and cytoplasmic loop (CL)-3, but not CL-1 or CL-2. Alanine scanning mutagenesis demonstrated that positively charged amino acids in CL-3 were critical for NPM binding. Recombinant NPM decreased GTP binding in membrane fractions after activation of CXCR4 by CXCL12. Suppression of NPM expression enhanced chemotactic responses to CXCL12, and, conversely, overexpression of a cytosolic NPM mutant reduced chemotaxis induced by CXCL12. This study provides evidence for a novel role for NPM as a negative regulator of CXCR4 signaling induced by CXCL12 that may be relevant to the biology of AML.",
author = "Wenbo Zhang and Navenot, {Jean Marc} and Frilot, {Nicole M.} and Nobutaka Fujii and Peiper, {Stephen C.}",
year = "2007",
month = "11",
doi = "10.1124/mol.107.037119",
language = "English (US)",
volume = "72",
pages = "1310--1321",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "5",

}

TY - JOUR

T1 - Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis

AU - Zhang, Wenbo

AU - Navenot, Jean Marc

AU - Frilot, Nicole M.

AU - Fujii, Nobutaka

AU - Peiper, Stephen C.

PY - 2007/11

Y1 - 2007/11

N2 - CXCR4, the primary receptor for CXCL12, plays a critical role in the development of hematopoietic, vascular, central nervous, and immune systems by mediating directional migration of precursor cells. This mechanism promotes homing of tumor cells to metastatic sites that secrete CXCL12, and CXCR4 expression is a negative prognostic factor in acute myelogenous leukemia (AML). To elucidate mechanisms that regulate CXCR4 signaling, we used a proteomic approach to identify proteins physically associated with CXCR4. Analysis of CXCR4 immune complexes identified nucleophosmin (NPM), which was confirmed by reciprocal coimmunoprecipitation for NPM. Constitutively active CXCR4 variants bound higher levels of NPM than the wild-type receptor, which was reversed by T140, an inverse agonist. NPM binding to CXCR4 localized interactions to the C terminus and cytoplasmic loop (CL)-3, but not CL-1 or CL-2. Alanine scanning mutagenesis demonstrated that positively charged amino acids in CL-3 were critical for NPM binding. Recombinant NPM decreased GTP binding in membrane fractions after activation of CXCR4 by CXCL12. Suppression of NPM expression enhanced chemotactic responses to CXCL12, and, conversely, overexpression of a cytosolic NPM mutant reduced chemotaxis induced by CXCL12. This study provides evidence for a novel role for NPM as a negative regulator of CXCR4 signaling induced by CXCL12 that may be relevant to the biology of AML.

AB - CXCR4, the primary receptor for CXCL12, plays a critical role in the development of hematopoietic, vascular, central nervous, and immune systems by mediating directional migration of precursor cells. This mechanism promotes homing of tumor cells to metastatic sites that secrete CXCL12, and CXCR4 expression is a negative prognostic factor in acute myelogenous leukemia (AML). To elucidate mechanisms that regulate CXCR4 signaling, we used a proteomic approach to identify proteins physically associated with CXCR4. Analysis of CXCR4 immune complexes identified nucleophosmin (NPM), which was confirmed by reciprocal coimmunoprecipitation for NPM. Constitutively active CXCR4 variants bound higher levels of NPM than the wild-type receptor, which was reversed by T140, an inverse agonist. NPM binding to CXCR4 localized interactions to the C terminus and cytoplasmic loop (CL)-3, but not CL-1 or CL-2. Alanine scanning mutagenesis demonstrated that positively charged amino acids in CL-3 were critical for NPM binding. Recombinant NPM decreased GTP binding in membrane fractions after activation of CXCR4 by CXCL12. Suppression of NPM expression enhanced chemotactic responses to CXCL12, and, conversely, overexpression of a cytosolic NPM mutant reduced chemotaxis induced by CXCL12. This study provides evidence for a novel role for NPM as a negative regulator of CXCR4 signaling induced by CXCL12 that may be relevant to the biology of AML.

UR - http://www.scopus.com/inward/record.url?scp=35548929059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548929059&partnerID=8YFLogxK

U2 - 10.1124/mol.107.037119

DO - 10.1124/mol.107.037119

M3 - Article

VL - 72

SP - 1310

EP - 1321

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 5

ER -